Gene expression analyses of grade II gliomas and identification of rPTPβ/ζ as a candidate oligodendroglioma marker

Neuro-Oncology

Volumn 10, Issue 1, 2008, Pages 2-9

  Hägerstrand, Daniel ^a   Smits, Anja ^b   Eriksson, Anna ^a   Sigurdardottir, Sunna ^b   Olofsson, Tommie ^c   Hartman, Magdalena ^c   Nistér, Monica ^a   Kalimo, Hannu ^c,d   Östman, Arne ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Grade II glioma; Histological marker; Microarray; Oligodendroglioma; rPTP

Indexed keywords

GENE PRODUCT; PROTEIN RPTPBETA; PROTEIN RPTPZETA; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASTROCYTE; ASTROCYTOMA; CANCER CLASSIFICATION; CANCER GRADING; CLINICAL ARTICLE; FEMALE; GENE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OLIGODENDROGLIOMA; RPTPBETA GENE; RPTPZETA GENE; VALIDATION PROCESS;

ADULT; BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OLIGODENDROGLIOMA; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 5; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 39149090663     PISSN: 15228517     EISSN: None     Source Type: Journal    
DOI: 10.1215/15228517-2007-041     Document Type: Article

References (32)

1. Bampoe J, Bernstein M. The role of surgery in low grade gliomas. J Neurooncol. 1999;42:259-269.
2. Davis FG, McCarthy BJ. Epidemiology of brain tumors. Curr Opin Neurol. 2000;13:635-640.
3. McLendon RE, Cleveland L, Pegram C, Bigner SH, Bigner DD, Friedman HS. Immunohistochemical detection of the DNA repair enzyme O6-methylguanine-DNA methyltransferase in formalin-fixed, paraffin-embedded astrocytomas. Lab Invest. 1998;78:643-644.
4. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61:215-225; discussion 226-229.
5. Leighton C, Fisher B, Bauman G, et al. (1997) Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation. J Clin Oncol. 1997;15:1294-1301.
6. Keles GE, Lamborn KR, Berger MS. Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg. 2001;95:735-745.
7. Karim AB, Afra D, Cornu P, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys. 2002;52:316-324.
8. Pignatti F, Van Den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol. 2002;20:2076-2084.
9. Reifenberger G, Louis DN. Oligodendroglioma: toward molecular definitions in diagnostic neuro-oncology. J Neuropathol Exp Neurol. 2003;62:111-126.
10. Kleihues P, Cavenee WK. Pathology and Genetics: Tumours of the Nervous System. World Health Organization Classification of Tumours. New York: Oxford University Press; 2000.
11. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA. 1998;95:14863-14868.
12. McShane LM, Radmacher MD, Freidlin B, Yu R, Li MC, Simon, R. Methods for assessing reproducibility of clustering patterns observed in analyses of microarray data. Bioinformatics. 2002;18:1462-1469.
13. Tamayo P, Slonim D, Mesirov J, et al. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci USA. 1999;96:2907-2912.
14. Reich M, Ohm K, Angelo M, Tamayo P, Mesirov JP. GeneCluster 2.0: an advanced toolset for bioarray analysis. Bioinformatics. 2004;20:1797-1798.
15. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 1999;286:531-537
16. Pavlidis P, Qin J, Arango JJ, Sibille E. Using the gene ontology for microarray data mining: a comparison of methods and application to age effects in human prefrontal cortex. Neurochem Res. 2004;29:1213-1222.
17. Mischel PS, Cloughesy TF, Nelson SF. DNA-microarray analysis of brain cancer: molecular classification for therapy. Nat Rev Neurosci. 2004;5:782-792.
18. Rich JN, Hans C, Jones B, et al. Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res. 2005;65:4051-4058.
19. Freije WA, Castro-Vargas FE, Fang Z, et al. Gene expression profiling of gliomas strongly predicts survival. Cancer Res. 2004;64:6503-6510.
20. Nutt CL, Mani DR, Betensky RA, et al. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res. 2003;63:1602-1607
21. Phillips HS, Kharbanda S, Chen R, et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006;9:157-173.
22. Tso CL, Freije WA, Day A, et al. Distinct transcription profiles of primary and secondary glioblastoma subgroups. Cancer Res. 2006;66:159-167
23. Shai R, Shi T, Kremen TJ, et al. Gene expression profiling identifies molecular subtypes of gliomas. Oncogene. 2003;22:4918-4923.
24. Huang H, Okamoto Y, Yokoo H, et al. Gene expression profiling and subgroup identification of oligodendrogliomas. Oncogene. 2004;23:6012-6022.
25. Muller S, Lamszus K, Nikolich K, Westphal M. Receptor protein tyrosine phosphatase zeta as a therapeutic target for glioblastoma therapy. Expert Opin Ther Targets. 2004;8:211-220.
26. Holland SJ, Peles E, Pawson T, Schlessinger J. Cell-contact-dependent signalling in axon growth and guidance: Eph receptor tyrosine kinases and receptor protein tyrosine phosphatase beta. Curr Opin Neurobiol. 1998;8:117-127.
27. Li J, Tullai JW, Yu WH, Salton SR. Regulated expression during development and following sciatic nerve injury of mRNAs encoding the receptor tyrosine phosphatase HPTPzeta/RPTPbeta. Brain Res Mol Brain Res. 1998;60:77-88.
28. Stoker A, Dutta R. Protein tyrosine phosphatases and neural development. Bioessays. 1998;20:463-472.
29. Muller S, Kunkel P, Lamszus K, et al. A role for receptor tyrosine phosphatase zeta in glioma cell migration. Oncogene. 2003;22:6661-6668.
30. Maeda, N, Noda M. Involvement of receptor-like protein tyrosine phosphatase zeta/RPTPbeta and its ligand pleiotrophin/heparin-binding growth-associated molecule (HB-GAM) in neuronal migration. J Cell Biol. 1998;142:203-216.
31. Harroch S, Furtado GC, Brueck W, et al. A critical role for the protein tyrosine phosphatase receptor type Z in functional recovery from demyelinating lesions. Nat Genet. 2000;32:411-414.
32. Foehr ED, Lorente G, Kuo J, Ram R, Nikolich K, Urfer, R. Targeting of the receptor protein tyrosine phosphatase beta with a monoclonal antibody delays tumor growth in a glioblastoma model. Cancer Res. 2006;66:2271-2278.